Immix Biopharma CFO and President Gabriel Morris reports $10,011.08 common share acquisition
IMMX•Immix Biopharma CFO, President and director Gabriel S. Morris purchased 1,418 common shares at $7.06 each, increasing his direct holdings to 292,847 shares.
1. Share purchase
Gabriel S. Morris purchased 1,418 Immix Biopharma common shares at $7.06 each. His direct holdings rose to 292,847 shares; separately reported indirect holdings were 426,844 shares and 24,141 shares.




